Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |